214 related articles for article (PubMed ID: 21386890)
41. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
[TBL] [Abstract][Full Text] [Related]
42. Reprogramming the pluripotent cell cycle: restoration of an abbreviated G1 phase in human induced pluripotent stem (iPS) cells.
Ghule PN; Medina R; Lengner CJ; Mandeville M; Qiao M; Dominski Z; Lian JB; Stein JL; van Wijnen AJ; Stein GS
J Cell Physiol; 2011 May; 226(5):1149-56. PubMed ID: 20945438
[TBL] [Abstract][Full Text] [Related]
43. Accelerated generation of human induced pluripotent stem cells with retroviral transduction and chemical inhibitors under physiological hypoxia.
Shimada H; Hashimoto Y; Nakada A; Shigeno K; Nakamura T
Biochem Biophys Res Commun; 2012 Jan; 417(2):659-64. PubMed ID: 22172948
[TBL] [Abstract][Full Text] [Related]
44. Development of feeder-free culture systems for generation of ckit+sca1+ progenitors from mouse iPS cells.
Lin J; Fernandez I; Roy K
Stem Cell Rev Rep; 2011 Sep; 7(3):736-47. PubMed ID: 21188655
[TBL] [Abstract][Full Text] [Related]
45. Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes.
Liu H; Ye Z; Kim Y; Sharkis S; Jang YY
Hepatology; 2010 May; 51(5):1810-9. PubMed ID: 20432258
[TBL] [Abstract][Full Text] [Related]
46. Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogramming.
Vaziri H; Chapman KB; Guigova A; Teichroeb J; Lacher MD; Sternberg H; Singec I; Briggs L; Wheeler J; Sampathkumar J; Gonzalez R; Larocca D; Murai J; Snyder E; Andrews WH; Funk WD; West MD
Regen Med; 2010 May; 5(3):345-63. PubMed ID: 20230312
[TBL] [Abstract][Full Text] [Related]
47. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
48. CG hypomethylation in Lsh-/- mouse embryonic fibroblasts is associated with de novo H3K4me1 formation and altered cellular plasticity.
Yu W; Briones V; Lister R; McIntosh C; Han Y; Lee EY; Ren J; Terashima M; Leighty RM; Ecker JR; Muegge K
Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5890-5. PubMed ID: 24711395
[TBL] [Abstract][Full Text] [Related]
49. Epigenetic Memory: Lessons From iPS Cells Derived From Human β Cells.
Efrat S
Front Endocrinol (Lausanne); 2020; 11():614234. PubMed ID: 33584546
[TBL] [Abstract][Full Text] [Related]
50. Generation of murine hepatic lineage cells from induced pluripotent stem cells.
Gai H; Nguyen DM; Moon YJ; Aguila JR; Fink LM; Ward DC; Ma Y
Differentiation; 2010 Mar; 79(3):171-81. PubMed ID: 20106584
[TBL] [Abstract][Full Text] [Related]
51. DNA methylation plasticity of human adipose-derived stem cells in lineage commitment.
Berdasco M; Melguizo C; Prados J; Gómez A; Alaminos M; Pujana MA; Lopez M; Setien F; Ortiz R; Zafra I; Aranega A; Esteller M
Am J Pathol; 2012 Dec; 181(6):2079-93. PubMed ID: 23031258
[TBL] [Abstract][Full Text] [Related]
52. Transient naive reprogramming corrects hiPS cells functionally and epigenetically.
Buckberry S; Liu X; Poppe D; Tan JP; Sun G; Chen J; Nguyen TV; de Mendoza A; Pflueger J; Frazer T; Vargas-Landín DB; Paynter JM; Smits N; Liu N; Ouyang JF; Rossello FJ; Chy HS; Rackham OJL; Laslett AL; Breen J; Faulkner GJ; Nefzger CM; Polo JM; Lister R
Nature; 2023 Aug; 620(7975):863-872. PubMed ID: 37587336
[TBL] [Abstract][Full Text] [Related]
53. Generation of germline-competent induced pluripotent stem cells.
Okita K; Ichisaka T; Yamanaka S
Nature; 2007 Jul; 448(7151):313-7. PubMed ID: 17554338
[TBL] [Abstract][Full Text] [Related]
54. DNA hypermethylation in somatic cells correlates with higher reprogramming efficiency.
Barrero MJ; Berdasco M; Paramonov I; Bilic J; Vitaloni M; Esteller M; Izpisua Belmonte JC
Stem Cells; 2012 Aug; 30(8):1696-702. PubMed ID: 22653871
[TBL] [Abstract][Full Text] [Related]
55. Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines.
Féraud O; Valogne Y; Melkus MW; Zhang Y; Oudrhiri N; Haddad R; Daury A; Rocher C; Larbi A; Duquesnoy P; Divers D; Gobbo E; Brunet de la Grange P; Louache F; Bennaceur-Griscelli A; Mitjavila-Garcia MT
PLoS One; 2016; 11(3):e0149291. PubMed ID: 26938212
[TBL] [Abstract][Full Text] [Related]
56. Mouse-induced pluripotent stem cells generated under hypoxic conditions in the absence of viral infection and oncogenic factors and used for ischemic stroke therapy.
Liu SP; Fu RH; Wu DC; Hsu CY; Chang CH; Lee W; Lee YD; Liu CH; Chien YJ; Lin SZ; Shyu WC
Stem Cells Dev; 2014 Feb; 23(4):421-33. PubMed ID: 24266622
[TBL] [Abstract][Full Text] [Related]
57. Neuropotent self-renewing neural stem (NS) cells derived from mouse induced pluripotent stem (iPS) cells.
Onorati M; Camnasio S; Binetti M; Jung CB; Moretti A; Cattaneo E
Mol Cell Neurosci; 2010 Mar; 43(3):287-95. PubMed ID: 20026276
[TBL] [Abstract][Full Text] [Related]
58. Investigating cellular identity and manipulating cell fate using induced pluripotent stem cells.
Sugawara T; Nishino K; Umezawa A; Akutsu H
Stem Cell Res Ther; 2012 Mar; 3(2):8. PubMed ID: 22405125
[TBL] [Abstract][Full Text] [Related]
59. Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells.
Galende E; Karakikes I; Edelmann L; Desnick RJ; Kerenyi T; Khoueiry G; Lafferty J; McGinn JT; Brodman M; Fuster V; Hajjar RJ; Polgar K
Cell Reprogram; 2010 Apr; 12(2):117-25. PubMed ID: 20677926
[TBL] [Abstract][Full Text] [Related]
60. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
Okada M; Yoneda Y
Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
